Embla Medical hf
Embla Medical hf, formerly operating as Ossur hf, is an Icelandic medical technology enterprise specializing in non-invasive orthopedics. The company designs, manufactures, and distributes advanced prosthetic limbs, osteoarthritis braces, and injury supports. Its product lineup encompasses bionic prosthetics, micro-processor knee joints, spinal bracing, and custom orthopedic mobility solutions under established brand families. Revenue is generated from product sales directly to orthopedic clinics, prosthetists, rehabilitation centers, and medical device distributors globally. Embla Medical holds a commanding global market position in prosthetic devices and mobility aids, leveraging continuous research and development. The company is headquartered in Reykjavik, Iceland, and its shares are listed on Nasdaq Copenhagen.
9 of the funds FundTelligence covers report a position in Embla Medical hf.
- Sector
- Health Care
- Country
- Iceland
- Funds holding it
- 9
Funds holding Embla Medical hf
- Schroder ISF Nordic Smaller Companies — Schroders · 2.61 % (full portfolio disclosed, June 2026)
- SEB Sverigefond Småbolag — SEB · 1.94 % (full portfolio disclosed, June 2026)
- SEB Sverigefond Småbolag Chans/Risk — SEB · 1.57 % (full portfolio disclosed, June 2026)
- Handelsbanken Norden Selektiv — Handelsbanken · 1.45 % (full portfolio disclosed, October 2026)
- Protean Aktiesparfond Norden — Protean · 1.31 % (full portfolio disclosed, June 2026)
- Swedbank Robur Småbolagsfond Norden — Swedbank · 1.11 % (full portfolio disclosed, October 2026)
- Handelsbanken Europa SMB — Handelsbanken · 0.89 % (full portfolio disclosed, October 2026)
- Handelsbanken Nordiske SMB — Handelsbanken · 0.26 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 9 funds holding it.